news from CHEIRON PHARMA

(Business review 2016)

In 2016, the services of Cheiron Pharma have reached a record high with more than 100 customers in more than 20 countries with about 200 different products.

(August 2016)

Only 4 months after receipt of the NARCOTIC LICENCE, Cheiron Pharma has started successfully the business in that product range with active pharmaceutical ingredients (like Codeine Phosphate, Fentanyl Citrate, Remifentanyl HCL, and others).

(May 2016)

Carsten Loebel and Stefan Thomsen will attend the CPhI in Barcelona (Oct. 4th-6th, 2016). We are looking forward to meeting you there for fruitful business discussions.

(April 2016)

Cheiron Pharma has received the Narcotic License as per § 3 BtMG (as per Narcotic Drug Law) and is including controlled substances in its product portfolio.

(March 2016)

Cheiron Pharma has applied for the Narcotic License as per § 3 BtMG (as per Narcotic Drug Law) in order to include controlled substances in its product portfolio.

(March 2016)

Business in Turkey is continuously growing. Consequently Cheiron Pharma will again attend CPhI in Istanbul from June 1 – 3, 2016.

(February 2016)

Cheiron Pharma will attend API in Shanghai from April 18 – 20, 2016 in order to deepen the relations with its Chinese business partners.

(October 2015)

Carsten Loebel and Stefan Thomsen will attend the CPhI in Madrid. They are looking forward to welcoming our business partners and getting to know further contacts.

Cookies make it easier for us to provide you with our services.
With the usage of our services you permit us to use cookies.